Skip to content

Aerobic Muscle Capacity in PPS.

Aerobic Muscle Capacity in patients with Postpoliomyelitis Syndrome (PPS).

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON20931
Enrollment
60
Registered
2010-11-09
Start date
2010-11-12
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postpoliomyelitis Syndrome, Neuromuscular diseases, Fatigue, Skeletal muscle, Aerobic capacity Postpoliomyelitis Syndroom, Neuromusculaire aandoeningen, Vermoeidheid, (Skelet)spieren, Aerobe inspanning

Interventions

None listed

Sponsors

Academic Medical Center (AMC), Department of Rehabiliation
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients: Diagnosis of PPS according to the criteria of March of Dimes (2000)*: 1. A confirmed history of paralytic poliomyelitis characterized by an acute illness with fever and a usually asymmetrically distributed, flaccid paresis of a varying number of muscle groups. Evidence of motor neuron loss on neurological examination with signs of residual weakness, atrophy, loss of tendon reflexes and intact sensation; 2. A period of partial or complete functional recovery after acute paralytic poliomyelitis, followed by an interval (usually 15 years or more) of stable neurologic function; 3. Gradual or sudden onset of progressive and persistent new muscle weakness or abnormal muscle fatigability (decreased endurance), with or without generalized fatigue, muscle atrophy, or muscle and joint pain. Symptoms persist for at least a year; 4. No other medical diagnosis to explain the symptoms. Control subjects: Healthy volunteers, matched for age, physical activity level, gender, body weigth and height. *March of Dimes Birth Defects Foundation. Identifying Best Practices in Diagnosis & Care Warm Springs, GA: March of Dimes International Conference on Post-Polio Syndrome. 2000.

Exclusion criteria

Exclusion criteria: Patients and control subjects: 1. Disabling co-morbidity influencing the outcome parameters (including cardiopulmonary disease like chest pain, arrhythmia, pacemaker, cardiac surgery, severe dyspnoea d’effort or emphysema, epileptic seizures, poorly regulated diabetes mellitus); 2. Inability to cycle on a bicycle ergometer; 3. Inability to activate the knee extensor muscles.

Design outcomes

Primary

MeasureTime frame
Variables for peripheral muscle properties include: 1. Critical torque (Nm); 2. Fatigue index (%); 3. Rate of torque development/decline (%)These will be determined with maximal voluntary contractions and (submaximal) electrically evoked contractions of the knee extensor muscles. Variables for aerobic exercise capacity include: 1. VO2peak (ml/min/kg); 2. VO2 at anaerobic threshold (ml/min/kg); 3. Power output at anaerobic threshold (W); 4. Heart rate at anaerobic threshold (bpm). These will be determined during graded exercise testing on a cycle ergometer.

Secondary

MeasureTime frame
Multiple measures of muscle strength and muscle activation will be determined: 1. Maximal Voluntary Contraction (MVC) (Nm); 2. Voluntary Activation (%); 3. Peripheral fatigue and Central fatigue (%).

Contacts

Public ContactE.L. Voorn

PO Box 22660

e.l.voorn@amc.uva.nl+31 (0)20 5668250

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)